Latest Executive Appointment News

Mamba Exploration Limited has agreed to acquire a 70% interest in the Meeka East Gold Project in Western Australia’s Murchison Goldfield, supported by a $2 million capital raise to fund exploration activities.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

A handful of small caps ripped higher, but plenty still slipped even after good news. This week’s biggest moves came from a platform partnership win, a reinstated stock, and a cash settlement that removed a long-running dispute.

JAYRIDE Group Limited advances its transformation into a scalable Mobility-as-a-Service platform with a new SaaS agreement in Thailand, strategic partnerships, and a successful capital raise. The company tightens its cost base while preparing for ASX reinstatement.

Securelink Networks has increased its stake in the PT&T joint venture to 50.1%, securing effective control, while its VSN Plus product gains strong traction in the Philippine market. The company also advances its ASX re-listing efforts amid ongoing cost reductions.

Dalaroo Metals has completed its strategic acquisition of the Blue Lagoon critical minerals project in Greenland and is advancing gold exploration in Côte d’Ivoire, supported by new executive appointments and promising assay results.

Many Peaks Minerals has reported robust high-grade gold drilling results at its Ferké and Odienné projects in Côte d'Ivoire, alongside a solid financial footing with nearly A$13 million in cash and investments.

Estrella Resources has reported multiple high-grade manganese intersections at its Ira Miri project, including assays up to 58% manganese, and received regulatory approval for a 30,000-tonne bulk sample extraction. Concurrently, drilling at the Werumata limestone project has been completed with assay results pending.

Forrestania Resources Limited has made significant strides in its expansion strategy during Q2 2025/2026, marked by the acquisition of Kula Gold Ltd, a substantial capital raise, and multiple project acquisitions across Western Australia.

Vitura Health has announced the departure of CEO Geoff Cockerill, appointing Chief Revenue Officer Ryan Tattle as interim leader while accelerating the search for a new CEO. Incoming CFO Andrew Cook will join ahead of schedule, signalling a renewed focus on operational and financial discipline.

Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent and is preparing for a key FDA submission, while appointing a new president to lead its US operations.

NoviqTech Limited has secured a controlling stake in Coralia, an Australian biochar carbon removal company, positioning itself at the forefront of the rapidly expanding carbon dioxide removal market driven by data centre growth.